for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Top News

Breakingviews: Superbug M&A

Posted

Robert Cyran tells Richard Beales why Merck is spending $8.4 bln on Cubist – a biotech specializing in until recently unfashionable antibiotics.

Top News

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up